107 related articles for article (PubMed ID: 22023892)
1. Not only accumulation, but also saturation status of intramuscular lipids is significantly affected by PPARγ activation.
Chabowski A; Zendzian-Piotrowska M; Nawrocki A; Górski J
Acta Physiol (Oxf); 2012 May; 205(1):145-58. PubMed ID: 22023892
[TBL] [Abstract][Full Text] [Related]
2. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
Smith AC; Mullen KL; Junkin KA; Nickerson J; Chabowski A; Bonen A; Dyck DJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E172-81. PubMed ID: 17374701
[TBL] [Abstract][Full Text] [Related]
3. Effects of hyperthyroidism on lipid content and composition in oxidative and glycolytic muscles in rats.
Miklosz A; Chabowski A; Zendzian-Piotrowska M; Gorski J
J Physiol Pharmacol; 2012 Aug; 63(4):403-10. PubMed ID: 23070090
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.
Benton CR; Koonen DP; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heikkila JJ; Bonen A
J Physiol; 2006 May; 573(Pt 1):199-210. PubMed ID: 16484294
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone increases fatty acid Δ9-desaturation and decreases elongase activity index in human skeletal muscle in vivo.
Mai K; Andres J; Bobbert T; Assmann A; Biedasek K; Diederich S; Graham I; Larson TR; Pfeiffer AF; Spranger J
Metabolism; 2012 Jan; 61(1):108-16. PubMed ID: 21741058
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.
Lessard SJ; Rivas DA; Chen ZP; Bonen A; Febbraio MA; Reeder DW; Kemp BE; Yaspelkis BB; Hawley JA
Diabetes; 2007 Jul; 56(7):1856-64. PubMed ID: 17440174
[TBL] [Abstract][Full Text] [Related]
7. Chronic, in vivo, PPARalpha activation prevents lipid overload in rat liver induced by high fat feeding.
Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Harasim E; Górski J
Adv Med Sci; 2009; 54(1):59-65. PubMed ID: 19403437
[TBL] [Abstract][Full Text] [Related]
8. Exercise reverses high-fat diet-induced impairments on compartmentalization and activation of components of the insulin-signaling cascade in skeletal muscle.
Yaspelkis BB; Lessard SJ; Reeder DW; Limon JJ; Saito M; Rivas DA; Kvasha I; Hawley JA
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E941-9. PubMed ID: 17623749
[TBL] [Abstract][Full Text] [Related]
9. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
Chen Y; Li Y; Wang Y; Wen Y; Sun C
Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance.
Todd MK; Watt MJ; Le J; Hevener AL; Turcotte LP
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E485-93. PubMed ID: 17003244
[TBL] [Abstract][Full Text] [Related]
11. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Gorski J
J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
[TBL] [Abstract][Full Text] [Related]
13. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
Laurent D; Gounarides JS; Gao J; Boettcher BR
Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone reduces fatty acid translocase and increases AMPK in skeletal muscle in aged rats: a possible mechanism to prevent high-fat-induced insulin resistance.
Song GY; Gao Y; Wang C; Hu SG; Wang J; Qu DM; Ma HJ
Chin Med J (Engl); 2010 Sep; 123(17):2384-91. PubMed ID: 21034554
[TBL] [Abstract][Full Text] [Related]
15. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
[TBL] [Abstract][Full Text] [Related]
16. A grape polyphenol extract modulates muscle membrane fatty acid composition and lipid metabolism in high-fat--high-sucrose diet-fed rats.
Aoun M; Michel F; Fouret G; Schlernitzauer A; Ollendorff V; Wrutniak-Cabello C; Cristol JP; Carbonneau MA; Coudray C; Feillet-Coudray C
Br J Nutr; 2011 Aug; 106(4):491-501. PubMed ID: 21554810
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle fatty acid handling in insulin resistant men.
van Hees AM; Jans A; Hul GB; Roche HM; Saris WH; Blaak EE
Obesity (Silver Spring); 2011 Jul; 19(7):1350-9. PubMed ID: 21331063
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
Sommer M; Wolf G
Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
[TBL] [Abstract][Full Text] [Related]
20. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
Berthiaume M; Laplante M; Tchernof A; Deshaies Y
Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
